DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Rifabutin

Rifabutin

  • CLINICAL USE of RIFABUTIN, a RIFAMYCIN-CLASS ANTIBIOTIC, for the TREATMENT of TUBERCULOSIS (A Supplement to the 2008 Revision Of“ Standards for Tuberculosis Care”)

    CLINICAL USE of RIFABUTIN, a RIFAMYCIN-CLASS ANTIBIOTIC, for the TREATMENT of TUBERCULOSIS (A Supplement to the 2008 Revision Of“ Standards for Tuberculosis Care”)

  • Rifabutin (Mycobutin) Reference Number: HIM.PA.12 Effective Date: 09.04.18 Last Review Date: 11.19 Revision Log Line of Business: HIM

    Rifabutin (Mycobutin) Reference Number: HIM.PA.12 Effective Date: 09.04.18 Last Review Date: 11.19 Revision Log Line of Business: HIM

  • RIFABUTIN Rifabutin Must Be Taken Regularly to Higher Risk of Bacterial Infection), Or Be Effective and to Prevent the Anemia (A Reduced Number of Red

    RIFABUTIN Rifabutin Must Be Taken Regularly to Higher Risk of Bacterial Infection), Or Be Effective and to Prevent the Anemia (A Reduced Number of Red

  • EMA/CVMP/158366/2019 Committee for Medicinal Products for Veterinary Use

    EMA/CVMP/158366/2019 Committee for Medicinal Products for Veterinary Use

  • E3 Appendix 1 (Part 1 of 2): Search Strategy Used in MEDLINE

    E3 Appendix 1 (Part 1 of 2): Search Strategy Used in MEDLINE

  • Customs Tariff - Schedule

    Customs Tariff - Schedule

  • Alphabetical Listing of ATC Drugs & Codes

    Alphabetical Listing of ATC Drugs & Codes

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Information for the User Mycobutin®150Mg Capsules Rifabutin Read All

    Information for the User Mycobutin®150Mg Capsules Rifabutin Read All

  • Therapy and Management of Pneumocystis Jirovecii Infection

    Therapy and Management of Pneumocystis Jirovecii Infection

  • A Computational Tool for Pathway-Based Rational Drug Repositioning Supplementary Information

    A Computational Tool for Pathway-Based Rational Drug Repositioning Supplementary Information

  • Antimicrobial Resistance in Bacteria

    Antimicrobial Resistance in Bacteria

  • Antibiotic Classes

    Antibiotic Classes

  • Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies

    Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies

  • Treatment and Prophylaxis of Opportunistic Infections in Hiv

    Treatment and Prophylaxis of Opportunistic Infections in Hiv

  • Treatment Shortening for (Drug-Susceptible) Pulmonary TB: Building

    Treatment Shortening for (Drug-Susceptible) Pulmonary TB: Building

  • Pneumonic Plague

    Pneumonic Plague

  • Dick Non-Rifampin Rifamycins in TB

    Dick Non-Rifampin Rifamycins in TB

Top View
  • Efficacy of Double Dose Dapsone Combination Therapy in The
  • Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals
  • Estonian Statistics on Medicines 2014
  • Ocular Toxicology and Pharmacology
  • WHO Regional Office for Europe Antimicrobial Medicines Consumption (AMC) Network: AMC Data, 2014-2018
  • Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
  • Common Antibiotics
  • Bacterial Challenges and Evolving Antibacterial Drug Strategy B
  • Development of New Novel Bacterial Topoisomerase Inhibitors As Promising Antibiotics with a 5-Amino-1,3-Dioxane Linker Moiety DI
  • Recommendations for Anti-Microbial Use for Secondary Infections in Patients with COVID-19 Rapid Review
  • RIFABUTIN Fact Sheet
  • Statistical Analysis Plan for Clinical Study Report Ac-061A301 / Ac
  • A Tale of Two Antibiotics
  • Rifabutin Capsules, USP
  • Using the Isoniazid/Rifapentine Regimen to Treat Latent Tuberculosis Infection (LTBI)
  • Norm Norm-Vet 2007
  • Rifamycin O, an Alternative Anti-Mycobacterium Abscessus Agent
  • Data Sheet Template


© 2024 Docslib.org    Feedback